| Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
2022 |
|
2021 |
|
2020 |
Earnings per share – basic: |
|
|
|
|
|
|
|
|
Net earnings, including noncontrolling interest |
|
263,099 |
|
|
139,585 |
|
|
229,296 |
Less net earnings (loss) attributable to noncontrolling interest |
|
(8,952) |
|
|
(825) |
|
|
— |
Net earnings attributable to Bio-Techne |
$ |
272,051 |
|
$ |
140,410 |
|
$ |
229,296 |
Income allocated to participating securities |
|
(121) |
|
|
(86) |
|
|
(224) |
Income available to common shareholders |
$ |
271,930 |
|
$ |
140,324 |
|
$ |
229,072 |
Weighted-average shares outstanding – basic |
|
39,219 |
|
|
38,747 |
|
|
38,201 |
Earnings per share – basic |
$ |
6.93 |
|
$ |
3.62 |
|
$ |
6.00 |
|
|
|
|
|
|
|
|
|
Earnings per share – diluted: |
|
|
|
|
|
|
|
|
Net earnings, including noncontrolling interest |
$ |
263,099 |
|
$ |
139,585 |
|
$ |
229,296 |
Less net earnings (loss) attributable to noncontrolling interest |
|
(8,952) |
|
|
(825) |
|
|
— |
Net earnings attributable to Bio-Techne |
|
272,051 |
|
|
140,410 |
|
|
229,296 |
Income allocated to participating securities |
|
(121) |
|
|
(86) |
|
|
(224) |
Income available to common shareholders |
$ |
271,930 |
|
$ |
140,324 |
|
$ |
229,072 |
Weighted-average shares outstanding – basic |
|
39,219 |
|
|
38,747 |
|
|
38,201 |
Dilutive effect of stock options and restricted stock units |
|
1,810 |
|
|
1,736 |
|
|
1,200 |
Weighted-average common shares outstanding – diluted |
|
41,029 |
|
|
40,483 |
|
|
39,401 |
Earnings per share – diluted |
$ |
6.63 |
|
$ |
3.47 |
|
$ |
5.82 |
|